Bank of New York Mellon
CVAC

Bank of New York Mellon’s CureVac CVAC Stock Holding History

Bank of New York Mellon’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,914
Closed -$69.6K – 4203
2025
Q3 		$69.6K Buy
12,914
+121
+0.9% +$655 ﹤0.01% 4117
2025
Q2 		$69.5K Sell
12,793
-260
-2% -$1.03K ﹤0.01% 4076
2025
Q1 		$36.2K Sell
13,053
-1,038
-7% -$3.61K ﹤0.01% 4067
2024
Q4 		$48.1K Buy
14,091
+170
+1% +$490 ﹤0.01% 4076
2024
Q3 		$40.9K Sell
13,921
-1,883
-12% -$6.2K ﹤0.01% 4052
2024
Q2 		$53.7K Buy
+15,804
New +$51.7K ﹤0.01% 4057
2022
Q2 		– Sell
-103,549
Closed -$2.03M – 4607
2022
Q1 		$2.03M Buy
103,549
+2,286
+2% +$45.6K ﹤0.01% 2935
2021
Q4 		$3.47M Buy
101,263
+18,537
+22% +$746K ﹤0.01% 2658
2021
Q3 		$4.52M Buy
82,726
+10,280
+14% +$619K ﹤0.01% 2538
2021
Q2 		$5.32M Buy
+72,446
New +$7.24M ﹤0.01% 2455

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Bank of New York Mellon's CVAC Position: Q4 2025 in Review

Bank of New York Mellon sold out of CureVac (CVAC) in Q4 2025, closing a stake of 12,914 shares — an estimated $69.6K sold.

Bank of New York Mellon first reported a position in CVAC in Q2 2021 and held it in 10 quarters. The position peaked at $5.32M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Bank of New York Mellon reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 12,914 CureVac shares in Q4 2025, an estimated $69.6K.
  • Bank of New York Mellon first reported a position in CureVac in Q2 2021 and held it in 10 quarters.
  • Bank of New York Mellon's CureVac position peaked at $5.32M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.